🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11 results for “Rocket Pharmaceuticals B.V.” Clear

  1. RP-A501

    Rocket Pharmaceuticals B.V.

    Danon Disease

    phase 2 gene therapy active

    2 trials

  2. RP-L102

    Rocket Pharmaceuticals B.V.

    Fanconi Anemia Complementation Group A

    phase 2 mab active

    3 trials

  3. RP-L201

    Rocket Pharmaceuticals B.V.

    Leukocyte Adhesion Defect - Type I

    phase 2 mab completed

    2 trials

  4. RP-L301

    Rocket Pharmaceuticals B.V.

    Pyruvate Kinase Deficiency

    phase 2 mab on hold

    2 trials

  5. Filgrastim

    Rocket Pharmaceuticals B.V.

    Fanconi Anemia

    phase 1 mab terminated

    1 trial

  6. RP-A601

    Rocket Pharmaceuticals B.V.

    PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

    phase 1 gene therapy active

    1 trial

  7. RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)

    Rocket Pharmaceuticals B.V.

    Dilated Cardiomyopathy (DCM)

    phase 1 gene therapy active

    1 trial

  8. RP-L401

    Rocket Pharmaceuticals B.V.

    Infantile Malignant Osteopetrosis

    phase 1 mab terminated

    1 trial

  9. SIS-reinforced anastomosis

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    approved other active

    1 trial

  10. Xuebijing

    Rocket Pharmaceuticals B.V.

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  11. Clostridium butyricum (live) Tablets(Meiya)

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources